News
Explore the ways Torx transforms information sharing to keep everyone on the same page, allowing you to focus more time on #chemistry. hubs.la/Q01zjkXK0 #medicinalchemistry #collaboration #drugdesign #chemistry #DMTA #pharma #biotech #drugdiscovery pic.twitter.com/MwaokViDVR
Cambridge, UK – 21 October 2021 – Torx Software Limited, provider of technology for managing small molecule discovery chemistry, announces ...
We are delighted to announce the release of the final modules of Torx™, your platform for small molecule discovery chemistry:
Discovery chemistry has progressed significantly in recent years. Researchers now have an abundance of information available to them, from computational ...
The ubiquitous Design-Make-Test-Analyze (DMTA) cycle provides a conerstone for drug discovery teams to consider and improve productivity. The challenge is ...
The delivery of synthesis targets within drug discovery often involves chemists from different organizations. Engaging contract research organization (CRO) partners ...
Chemistry teams working in small molecule discovery follow an iterative Design-Make-Test-Analyze (DMTA) cycle to design and optimize new therapeutics. Companies ...
Torx Design™ is a cloud-based platform that provides a central location to capture and share information about molecules, hypotheses and ...
Increased demands in pharmaceutical R&D have led to an increase in outsourcing The journey of a new drug from hypothesis ...
The importance of communication in drug discovery Every drug discovery program can be described using the iterative Design-Make-Test-Analyze (DMTA) workflow. ...
Design-Make-Test-Analyze Irrespective of the therapeutic area or target pathway, all small molecule discovery teams repeat a common workflow to optimize ...
Coordinating new molecule chemistry through the Design-Make-Test-Analyze (DMTA) cycle has never been more important or more challenging. Each project in ...
We are delighted to announce the launch of Torx™, a new platform for small molecule discovery chemistry.
